Current research
Covid-19 & Pregnancy
(Priority)
PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY), a nationwide registry of pregnant and postpartum women with or known or suspected COVID-19. Our team at UCLA has partnered with UCSF to establish this collaboration to answer critical questions for peripartum, neonatal, and postpartum patients with COVID-19 nationally and globally. Little is known about COVID-19 and its longstanding impact for women and babies. A robust research platform is needed to better understand the pathways of COVID-19 to identify risk factors and develop effective treatments. Our work includes maternal and neonatal outcomes and a biospecimen core to answer clinically relevant questions.​​​
"the first ones who need the masks are pregnant women"
Why Pregnant Women Face Special Risks From COVID-19
No association was found between maternal SARS-CoV-2 status and birth weight or respiratory problems.
The PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) study examines the effects of COVID-19 and SARS-CoV-2 on pregnancy. It found that pregnant patients exhibited different COVID-19 symptoms, like greater rates of fatigue and headaches and lower rates of fever. In addition, pregnant patients were more likely to experience prolonged symptoms.
Two pregnant women hospitalized due to COVID-19 related acute respiratory distress syndrome were observed to study the efficacy of extracorporeal membrane oxygenation as a treatment for pregnant women. In the end, neither women experienced complications, suggesting that ECMO can be used without endangering the fetus.
People with long COVID were surveyed about their lingering symptoms. The participants reported diverse effects like fatigue, cognitive dysfunction, sleep issues, as well as symptom relapses.​​​
Related Publications
Thank you
to our Supporters
